Interestingly, BM-MSCs and UC-MSCs from SLE patients have a defect in IDO activity and secretion, which is an enzyme that mediates tryptophan degradation into immunosuppression metabolites (54). The gene discussed is IDO1; the disease is systemic lupus erythematosus.